DAWN study Background
The DAWN Programme was created because more than half of people with diabetes do not achieve good health and quality of life, despite the availability of effective medical treatments.
Filling knowledge gaps
Although a considerable amount of psychosocial research had been carried out which pointed to psychosocial issues as the reason for poor outcomes, there were no large, truly global studies to map the problem.
Important gaps in knowledge existed, particularly concerning data which would (a) allow for international comparisons of management approaches to diabetes, (b) examine the complex relationships between the stakeholders – people with diabetes and their families, the physicians, the nurses and their support teams, and (c) enable policy makers and other stakeholders to recommend changes where needed.
The DAWN (Diabetes Attitudes Wishes and Needs) study in 2001 was a massive collaborative undertaking involving Novo Nordisk, the International Diabetes Federation and an international expert advisory board – the largest diabetes study of its kind ever conducted.